---
title: "Turn Therapeutics CEO to ring Nasdaq Closing Bell"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294063407.md"
description: "Turn Therapeutics CEO Bradley Burnam will ring the Nasdaq Closing Bell on August 10, 2026, at 3:45 p.m. ET from Nasdaq MarketSite in New York. This event marks progress since the company's direct listing in October 2025."
datetime: "2026-07-28T12:09:25.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294063407.md)
  - [en](https://longbridge.com/en/news/294063407.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294063407.md)
generator: "portal-rs"
---

# Turn Therapeutics CEO to ring Nasdaq Closing Bell

-   Turn Therapeutics will ring the Nasdaq Closing Bell on Aug. 10, 2026, marking progress since its October 2025 direct listing. \* CEO Bradley Burnam is scheduled to attend with the management team at Nasdaq MarketSite in Times Square, New York. \* The Closing Bell broadcast is set to begin at 3:45 p.m. ET. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Turn Therapeutics Inc. published the original content used to generate this news brief on July 28, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [TTRX.US](https://longbridge.com/en/quote/TTRX.US.md)

## Related News & Research

- [Turn Therapeutics sells 135,000 shares in private placement for $1.35 million](https://longbridge.com/en/news/296141997.md)
- [Turn Therapeutics says mouse study shows GX-03 cuts dermatitis severity 66%](https://longbridge.com/en/news/296487429.md)
- [Silexion Therapeutics faces Nasdaq delisting notice over minimum shareholders’ equity shortfall](https://longbridge.com/en/news/296649956.md)
- [Nykode Therapeutics to release Q2 financial results, host webcast presentation](https://longbridge.com/en/news/296641436.md)
- [IRLAB Therapeutics to webcast interim report presentation](https://longbridge.com/en/news/296470410.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**